We are live on ! Find out more
JA

JLB & Associates Portfolio holdings

AUM $696M
1-Year Est. Return 17.86%
This Fund
S&P 500
This Quarter Est. Return
-4.24%
1 Year Est. Return
+17.86%
3 Year Est. Return
+57.72%
5 Year Est. Return
+93.63%
10 Year Est. Return
AUM
$669M
AUM Growth
-$35.9M
Cap. Flow
+$4.33M
Cap. Flow %
0.65%
Top 10 Hldgs %
35.75%
Holding
79
New
2
Increased
52
Reduced
16
Closed
4

Top Buys

Rank Stock Value
1
KLAC icon
KLA
KLAC
+$2.53M
2
TNET icon
TriNet
TNET
+$2.45M
3
FFIV icon
F5
FFIV
+$1.26M
4
DLTR icon
Dollar Tree
DLTR
+$873K
5
ORLY icon
O'Reilly Automotive
ORLY
+$849K

Top Sells

Rank Stock Value
1
CTSH icon
Cognizant
CTSH
+$4.31M
2
NEU icon
NewMarket
NEU
+$3.31M
3
AAPL icon
Apple
AAPL
+$1.6M
4
GPN icon
Global Payments
GPN
+$845K
5
PII icon
Polaris
PII
+$634K

Sector Composition

Rank Sector Weight
1 Technology 22.03%
2 Industrials 17.61%
3 Financials 16.59%
4 Healthcare 15.43%
5 Consumer Discretionary 14.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNI icon
26
Canadian National Railway
CNI
$76.9B
$11.9M 1.78%
88,646
-709
-0.8% -$88.6K
EXPD icon
27
Expeditors International
EXPD
$21.8B
$11.7M 1.76%
113,888
+460
+0.4% +$50.7K
AME icon
28
Ametek
AME
$55B
$10.9M 1.64%
82,210
-1,459
-2% -$196K
ROST icon
29
Ross Stores
ROST
$81B
$10.7M 1.6%
118,243
+2,229
+2% +$212K
SYK icon
30
Stryker
SYK
$133B
$10.4M 1.56%
39,082
-298
-0.8% -$77.1K
ICLR icon
31
Icon
ICLR
$12.8B
$9.47M 1.42%
38,944
+381
+1% +$95.5K
PGR icon
32
Progressive
PGR
$124B
$8.59M 1.28%
75,399
+700
+0.9% +$75.7K
ABBV icon
33
AbbVie
ABBV
$455B
$8.53M 1.28%
52,648
+245
+0.5% +$35.6K
LLY icon
34
Eli Lilly
LLY
$1.03T
$8.33M 1.25%
29,090
-554
-2% -$143K
TROW icon
35
T. Rowe Price
TROW
$25.6B
$8.27M 1.24%
54,712
+3,591
+7% +$554K
HSIC icon
36
Henry Schein
HSIC
$9.7B
$7.71M 1.15%
88,429
+1,789
+2% +$146K
SHW icon
37
Sherwin-Williams
SHW
$83.7B
$7.5M 1.12%
30,062
+953
+3% +$263K
CTSH icon
38
Cognizant
CTSH
$24.3B
$6.15M 0.92%
68,592
-49,037
-42% -$4.31M
KLAC icon
39
KLA
KLAC
$236B
$6.11M 0.91%
167,000
+67,770
+68% +$2.53M
RHI icon
40
Robert Half
RHI
$3.81B
$5.53M 0.83%
48,415
+549
+1% +$63.3K
FDS icon
41
Factset
FDS
$9.35B
$4.93M 0.74%
11,364
+6
+0.1% +$2.53K
CACC icon
42
Credit Acceptance
CACC
$5.81B
$3.77M 0.56%
6,858
+919
+15% +$501K
INTC icon
43
Intel
INTC
$460B
$3.69M 0.55%
74,516
+6,230
+9% +$309K
CBRE icon
44
CBRE Group
CBRE
$43.3B
$3.45M 0.52%
37,716
+395
+1% +$38.5K
LOW icon
45
Lowe's Companies
LOW
$118B
$3.35M 0.5%
16,595
+309
+2% +$71.1K
TSM icon
46
TSMC
TSM
$2.09T
$3.2M 0.48%
30,717
+1,140
+4% +$133K
TNET icon
47
TriNet
TNET
$3.29B
$3.18M 0.48%
32,357
+27,668
+590% +$2.45M
SLGN icon
48
Silgan Holdings
SLGN
$4.34B
$3.09M 0.46%
66,918
-761
-1% -$33K
FFIV icon
49
F5
FFIV
$22.1B
$3.09M 0.46%
14,774
+6,015
+69% +$1.26M
HSY icon
50
Hershey
HSY
$35.9B
$2.99M 0.45%
13,794
+3,055
+28% +$620K

Similar funds

JLB & Associates's Q1 2022 Portfolio in Review

As of Q1 2022, JLB & Associates held 79 positions worth $669M, down 5.1% from $705M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

JLB & Associates's Q1 2022 filing shows 2 new, 52 increased, 16 reduced and 4 closed positions. Its largest new stake was Prudential Financial Inc 5.625% Junior Subordinated Notes due 2058: 9,042 shares worth $236K. The largest sale was Cognizant, an estimated $4.31M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Industrials and Financials.

  • JLB & Associates's largest Q1 2022 buy was Prudential Financial Inc 5.625% Junior Subordinated Notes due 2058: 9,042 shares worth $236K.
  • JLB & Associates added most to KLA in Q1 2022, an estimated $2.53M increase.
  • JLB & Associates's biggest Q1 2022 reduction was Cognizant, cutting an estimated $4.31M.
  • JLB & Associates fully exited Snap-on in Q1 2022, selling an estimated $446K.
  • JLB & Associates's ten largest holdings make up 36% of its $669M portfolio in Q1 2022.
  • JLB & Associates opened 2 new positions and closed 4 in Q1 2022.
  • JLB & Associates's portfolio value fell 5.1% quarter-over-quarter to $669M.

Based on JLB & Associates's 13F filing for Q1 2022, filed 8 Apr 2022.